The Agency for Healthcare Research and Quality (AHRQ) told researchers it will not continue long-awaited grant funding, sending letters citing the “best interest of the federal government.” The decision directly affects the pipeline of health-services and outcomes research supported by the agency and could disrupt work scheduled around planned continuations. The reports describe a break from expectations of funding continuation, with AHRQ using internal determinations rather than programmatic reassignment or documented review criteria publicly tied to specific deliverables. For university research compliance and sponsored-project teams, the immediate impact is on project timelines, staffing, and downstream deliverables. While details on individual awards were not included, the development highlights how federal research funding continuity can change quickly even when projects anticipate renewal. Higher education stakeholders will likely monitor whether other AHRQ awards face similar continuation decisions. The episode also raises near-term risk management questions for grant-funded investigators that coordinate budgets with multi-year deliverables and lab or clinical partnerships.